14.03.2016 • NewsoperationsManufacturingBiosuccinium

Ad Smolders Joins Reverdia As Operations Director

Reverdia has announced that Ad Smolders has joined the company as Operations...
Reverdia has announced that Ad Smolders has joined the company as Operations Director. Reverdia is a joint venture between DSM and Roquette and produces, markets and licenses bio-based succinic acid under the brand name Biosuccinium.

Reverdia has announced that Ad Smolders has joined the company as Operations Director. Reverdia is a joint venture between DSM and Roquette and produces, markets and licenses bio-based succinic acid under the brand name Biosuccinium.

Smolders previously worked at DSM for seventeen years in various international technology and manufacturing assignments. More recently, he has overseen an extensive number of operations projects, including the optimization of yeast plants, as a consultant and interim manager.

Marcel Lubben, Reverdia’s President said, “With his considerable experience in manufacturing and process improvement, Ad Smolders will lead Reverdia’s operations to the next stage of growth.  His leadership in manufacturing excellence will further bolster our low pH yeast technology. This will benefit both our clients out of Cassano and also our partners and licensees for future Biosuccinium plants.”   
 
 

Company

Reverdia

Urmonderbaan 20H
6167 RD Geleen

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.